---
title: "United Imaging Healthcare (688271): Won the procurement project of Chifeng Baoshan Hospital, with a bid amount of 1.26 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287854921.md"
description: "United Imaging Healthcare (688271) won the bid for the procurement project of Chifeng Baoshan Hospital, with an amount of 1.26 million yuan. The operating revenue for 2025 is expected to be 13.8 billion yuan, with a growth rate of 33.98%; the net profit is expected to be 1.869 billion yuan, with a growth rate of 48.14%. In the first quarter of 2026, the operating revenue is expected to be 2.908 billion yuan, with a growth rate of 17.34%; the net profit is expected to be 399 million yuan, with a growth rate of 7.78%"
datetime: "2026-05-28T03:42:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287854921.md)
  - [en](https://longbridge.com/en/news/287854921.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287854921.md)
generator: "portal-rs"
---

# United Imaging Healthcare (688271): Won the procurement project of Chifeng Baoshan Hospital, with a bid amount of 1.26 million yuan

According to Tongbi Finance, data from Qichacha shows that based on the "Announcement of the Bidding (Transaction) Results for the Procurement Project of Full Maintenance Services for the United Imaging UCT960+CT Equipment at Chifeng Baoshan Hospital," Shanghai United Imaging Healthcare Technology Co., Ltd. announced on May 28, 2026, that it won the procurement project for Chifeng Baoshan Hospital, with a bid amount of 1.26 million yuan.

Related listed company: United Imaging Healthcare (688271.SH)

*Tongbi Finance Tip:*

*United Imaging Healthcare (688271.SH) reported an operating income of 13.8 billion yuan in 2025, with an operating income growth rate of 33.98%. The net profit attributable to the parent company was 1.869 billion yuan, with a net profit growth rate of 48.14%, and a return on equity of 9.00%.*

*In the first quarter of 2026, the company's operating income was 2.908 billion yuan, with an operating income growth rate of 17.34%. The net profit attributable to the parent company was 399 million yuan, with a net profit growth rate of 7.78%.*

*Currently, the company belongs to the healthcare industry, with the main product type being diagnostic and therapeutic equipment. The 2025 report shows the main composition of revenue from sales of medical imaging diagnostic equipment and radiation therapy equipment: 82.53%; maintenance revenue: 12.38%; other businesses: 4.69%; software revenue: 0.39%.*

### Related Stocks

- [688271.CN](https://longbridge.com/en/quote/688271.CN.md)

## Related News & Research

- [03:58 ETUPMC Italy and United Imaging Healthcare bring Europe's first CE-marked uRT-linac 506c to Italy](https://longbridge.com/en/news/288031468.md)
- [Predict signs Italy healthcare distribution deal for Robocore’s “temi” service robots](https://longbridge.com/en/news/296769892.md)
- [Carvolix, Truffle Capital launch SAF-MD Saudi-French medical cooperation program](https://longbridge.com/en/news/296812494.md)
- [09:00 ETCoreline Soft and INFINITT North America Deploy Chest CT-Based AI Reading Workflow at St. Joseph's Health](https://longbridge.com/en/news/296621734.md)
- [Avanti Helium secures up to US $10 million convertible credit facility with RiverFort Global Opportunities](https://longbridge.com/en/news/296806980.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**